Treatment of stroke using isolated placental cells

Details for Australian Patent Application No. 2009283217 (hide)

Owner Anthrogenesis Corporation

Inventors Zeitlin, Andy; Pal, Ajai

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009283217

PCT Pub. Number WO2010/021715

Priority 61/090,565 20.08.08 US

Filing date 20 August 2009

Wipo publication date 25 February 2010

International Classifications

C12N 5/073 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Embryonic cells or tissues

A61K 35/50 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

17 March 2011 PCT application entered the National Phase

  PCT publication WO2010/021715 Priority application(s): WO2010/021715

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009283218-Diffusion device with odor sensor

2009283216-Improved cell composition and methods of making the same